An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

NCT03777436 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
289
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen